![]() |
|
|
Vol. 282, Issue 2, 574-584, 1997
-Acetylmethadol (LAAM), Buprenorphine and Methadone in
Morphine-Treated Rhesus Monkeys1
Department of Pharmacology and Experimental Therapeutics, Louisiana
State University Medical Center, New Orleans, Louisiana
The discriminative stimulus effects of l-
-acetylmethadol
(LAAM), l-
-acetylnormethadol (nor-LAAM),
l-
-acetyldinormethadol (dinor-LAAM), buprenorphine and
methadone were investigated in morphine-treated (3.2 mg/kg/day) rhesus
monkeys (n = 3-6) discriminating between saline and
naltrexone (0.01 mg/kg) and responding under a fixed ratio (FR)
schedule of stimulus-shock termination. Monkeys responded on the
naltrexone lever after either the administration of 0.01 mg/kg of
naltrexone or the substitution of saline for the daily dose of morphine
(i.e., 27-hr morphine deprived). Morphine dose-dependently
reversed naltrexone lever responding in morphine-deprived monkeys.
Methadone, LAAM, nor-LAAM and dinor-LAAM had morphine-like discriminative stimulus effects in all monkeys, whereas, buprenorphine had naltrexone-like discriminative stimulus effects in three monkeys and morphine-like effects in two monkeys; 24 hr after administration, buprenorphine antagonized the effects of morphine in the former and
antagonized the effects of naltrexone in the latter. The agonist and
antagonist effects of buprenorphine persisted for more than 6 days. The
relative duration of action was: buprenorphine > LAAM > nor-LAAM = methadone = dinor-LAAM = morphine. That
buprenorphine had markedly different discriminative stimulus effects in
monkeys treated identically with morphine is likely due to the low
efficacy of buprenorphine and emphasizes the difficulty in predicting
the behavioral effects of buprenorphine in opioid-dependent
individuals. The considerably longer duration of LAAM, than either
nor-LAAM or dinor-LAAM, indicates that the rate of metabolite formation is important for the long duration of LAAM and further suggests that
variations in metabolic activity among individuals might result in
differences in the behavioral effects of LAAM.
This article has been cited by other articles:
![]() |
S. L. Sell, L. R. McMahon, and C. P. France Relative Efficacy of Buprenorphine, Nalbuphine and Morphine in Opioid-Treated Rhesus Monkeys Discriminating Naltrexone J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1167 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Brandt and C. P. France Chronic l-alpha -Acetylmethadol (LAAM) in Rhesus Monkeys: Tolerance and Cross-Tolerance to the Antinociceptive, Ventilatory, and Rate-Decreasing Effects of Opioids J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 168 - 178. [Abstract] [Full Text] |
||||
![]() |
T. Eissenberg, M. L. Stitzer, G. E. Bigelow, A. R. Buchhalter, and S. L. Walsh Relative Potency of levo-alpha -Acetylmethadol and Methadone in Humans under Acute Dosing Conditions J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 936 - 945. [Abstract] [Full Text] |
||||
![]() |
M. R. Brandt and C. P. France Chronic l-Alpha Acetylmethadol in Rhesus Monkeys: Discriminative Stimulus and Other Behavioral Measures of Dependence and Withdrawal J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1029 - 1037. [Abstract] [Full Text] |
||||